psychiatric disorders high blood pressure, dyslipidemia, hypertrophy of the left ventricle, non-alcoholic steatohepatitis, alterations of endothelial function , hyperinsulinemia or insulin resistance, asthma, obstructive sleep apnea and orthopedic problems
Theyre positioning themselves as a full-service metabolic health solution rather than just a weight loss pill source
In one clinical trial funded by Eli Lilly, participants who took Tirzepatide 5.0 mg lost 16.1 kg of body weight, participants who took Tirzepatide 10 mg lost 22.2 kg of body weight, and participants who took Tirzepatide 15 mg lost 23.6 kg of body weight, while only 2.4 kg weight loss was observed in participants taking placebo
The comparative impulse can derive from multiple and often complementary motivations